Based on these accumulating data we hypothesized that the decreased cerebral glucose metabolism, which is an early and distinct characteristic of AD, may lead to decreased LXR activation and poor ApoE lipidation, which in turn may be responsible for decreased Aβ clearance, and, hence, its increased deposition in the AD brain [20]. Here, APOE is linked to Alzheimer disease.